PRRT2 and fibrosarcoma: In the NADPH oxidase-dependent pathway, PKC or the rapidly accelerated fibrosarcoma (Raf)-MEK-ERK pathway is activated [43], which results in the activation of NADPH oxidase and the generation of ROS.